Back to Zürcher Kantonalbank Zürcher Kantonalbank

MRNA

26 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Moderna, Inc.

Yes. Zürcher Kantonalbank holds 169,404 shares of MRNA (Moderna), worth $32.6M, as of its Q3 2026 13F filing. It increased the position by 7,229 shares (+4.5%) from Q2 2026. Zürcher Kantonalbank has held MRNA since Q2 2020, across 26 quarterly 13F filings. MRNA is 0.1% of Zürcher Kantonalbank's reported 13F portfolio.

Current Value

$32.6M

Current Shares

169,404

Total Value Change

+$28.9M

Total Shares Change

+111,325

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
169,404
+4.5%
$32.6M0.1%$192.57
30
2026-Q2
Increased
162,175
+1.3%
$11.4M0.0%$70.03
28
2026-Q1
Increased
160,161
+14.7%
$8.1M0.0%$50.80
31
2025-Q4
Increased
139,654
+19.2%
$4.1M0.0%$29.49
32
2025-Q3
Increased
117,169
+10.1%
$3M0.0%$25.83
29
2025-Q2
Decreased
106,454
-44.6%
$2.9M0.0%$27.59
0
2025-Q1
Decreased
192,306
-41.1%
$5.5M0.0%$28.35
0
2024-Q4
Increased
326,749
+107.1%
$13.6M0.0%$41.58
45
2024-Q3
Increased
157,774
+17.6%
$10.5M0.0%$65.75
32
2024-Q2
Increased
134,143
+0.7%
$15.9M0.1%$118.75
28
2024-Q1
Increased
133,247
+13.3%
$14.2M0.0%$106.56
32
2023-Q4
Increased
117,636
+75.2%
$11.7M0.0%$99.45
42
2023-Q3
Decreased
67,132
-0.3%
$6.9M0.0%$103.29
0
2023-Q2
Increased
67,338
+4.6%
$8.2M0.0%$122.11
29
2023-Q1
Decreased
64,382
-40.5%
$9.9M0.0%$147.44
0
2022-Q4
Decreased
108,138
-7.3%
$19.4M0.1%$179.62
0
2022-Q3
Decreased
116,654
-0.6%
$13.8M0.1%$118.07
0
2022-Q2
Decreased
117,393
-14.5%
$16.8M0.1%$142.81
0
2022-Q1
Increased
137,284
+29.5%
$23.6M0.1%$174.92
43
2021-Q4
Increased
105,986
+33.2%
$26.9M0.1%$251.60
44
2021-Q3
Increased
79,595
+0.2%
$30.6M0.2%$378.90
34
2021-Q2
Increased
79,424
+35.8%
$18.7M0.1%$234.46
44
2021-Q1
Increased
58,501
+3.6%
$7.7M0.0%$118.49
28
2020-Q4
Decreased
56,461
-23.6%
$5.9M0.0%$111.13
0
2020-Q3
Increased
73,906
+27.3%
$5.2M0.0%$70.52
34
2020-Q2
New
58,079
-
$3.7M0.0%$62.08
37

Other major holders of MRNA: Baillie Gifford & Co., FMR LLC

Optional analytics helps us improve. How it’s used